Clinical Trials About "Plexxikon Inc." RSS

16:46 EST 21st February 2020 | BioPortfolio

We list hundreds of Clinical Trials about "Plexxikon Inc." on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Plexxikon Inc." on BioPortfolio

We have published hundreds of Plexxikon Inc. news stories on BioPortfolio along with dozens of Plexxikon Inc. Clinical Trials and PubMed Articles about Plexxikon Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Plexxikon Inc. Companies in our database. You can also find out about relevant Plexxikon Inc. Drugs and Medications on this site too.

Showing "Plexxikon" Clinical Trials, all 1


A Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma

This open-label single arm study will assess the efficacy, safety and tolerability of RO5185426 in previously treated patients with metastatic melanoma. Patients will receive oral RO5185426 [RG7204; PLEXXIKON: PLX4032] at a dose of 960 mg b.i.d. continuously until disease progression or withdrawal from study and will be assessed at regular intervals for tumour response and tolerability. Target sample size is

More From BioPortfolio on "Plexxikon Inc."

Quick Search